[In silico specificity determination of neoantigen-reactive T-lymphocytes]

A E Kniga1, I V Polyakov1, A V Nemukhin1

  • 1M.V. Lomonosov Moscow State University, Moscow, Russia; N.M. Emanuel Institute of Biochemical Physics RAS, Moscow, Russia.

Insights

Future personalized immunotherapies require understanding both tumor and immune response specifics. This study develops structure-based models to predict T cell-tumor interactions, improving upon sequence-based methods for better cancer recognition.

Area of Science:

  • Computational Biology
  • Immunology
  • Structural Biology

Background:

  • Personalized immunotherapies demand comprehensive understanding of tumor-specific immune responses.
  • Predicting T cell receptor (TCR) and peptide-MHC (pMHC) interactions is crucial for effective immunotherapy design.

Purpose of the Study:

  • To develop and validate structure-based computational models for predicting TCR-pMHC interactions.
  • To identify key structural and energetic features governing T cell-mediated tumor recognition.

Main Methods:

  • In vitro high-throughput specificity assays were used to generate data.
  • Comparative modeling of TCR-pMHC complexes was performed using molecular docking.
  • All-atom models of pairwise TCR-pMHC combinations were constructed.
  • Physics-based scores were calculated and used to train binary classifiers.

Main Results:

  • Structure-based classifiers demonstrated superior performance compared to sequence-based methods.
  • Key energetic terms and structural features characterizing T cell-tumor interactions were identified.
  • The models accurately predict the specificity of T cell recognition.

Conclusions:

  • Computational modeling of TCR-pMHC complexes offers a powerful approach for predicting immune recognition.
  • These structure-based insights can guide the development of more effective personalized immunotherapies.
  • Understanding the structural basis of T cell-tumor interactions is vital for advancing cancer immunology.

Related Concept Videos